A groundbreaking development in heart health research has emerged, offering hope for a condition that affects countless individuals worldwide. Heart valve stiffness, a silent yet formidable foe, has met its match with a new 'humanized' model.
Researchers at the University of Missouri have crafted a unique platform to tackle this issue, aiming to test treatments for a condition caused by calcium buildup in the aortic valve. As we age, this 'door' of the heart, responsible for keeping blood flowing, can become a barrier, leading to potential heart failure.
Enter Shiyou Chen and Dunpeng Cai, faculty members at the School of Medicine's Department of Surgery, who have developed the first-ever 'humanized' model of aortic valve calcification. This breakthrough could be the key to discovering effective therapies to combat calcium buildup.
"Aortic valve disease is a prevalent issue, especially among middle-aged and older adults," Chen explains. "Currently, there's no effective treatment. Surgery is an option, but it's not always ideal for older patients. Our goal is to enable the research community and pharmaceutical companies to identify the first-ever effective treatment."
To bring this vision to life, Cai and Chen conducted an innovative experiment. They implanted human heart valve fragments into a human artery segment, which was then attached to a mouse's aorta, along with immune cells from the same patient. Chen credits Cai's exceptional microsurgery skills and the contributions of Drs. Lindsey Saint and John Markley for the study's success.
By observing the progression of aortic valve calcification in this 'humanized' model, researchers can now test potential treatments, aiming to develop medicine that can stop or reverse calcium buildup in the aortic valve.
Chen emphasizes the impact of Mizzou's interdisciplinary collaboration, bringing together scientists, surgeons, clinicians, and veterinary medicine experts. "Mizzou's support has been instrumental in making our research impactful in the medical field. With heart disease being the leading cause of death globally, our work has the potential to make a significant difference."
The research, titled "Novel Humanized Aortic Valve Calcification Model," was published in Circulation Research. This development offers a glimmer of hope for those affected by heart valve stiffness, and the research community eagerly awaits the outcomes of potential treatments.
